According to latest research report published by MarketsandMarkets, the Europe AI in Drug Discovery Market by Offering (Software, Service), Technology (Machine Learning, Deep Learning), Application (Cardiovascular, Metabolic, Neurodegenerative), End User (Pharma, Biotech,CROs) - Global Forecasts to 2027, is expected to grow at a CAGR of 45.7% from 2022 to 2027.
Here are some of the key trends that are expected to drive the growth of the AI in Drug Discovery Market in Europe:
The AI in Drug Discovery Market in Europe is expected to be a major market for the development of new drugs in the coming years. The growth of this market will be driven by the increasing demand for new and innovative drugs, the rising prevalence of chronic diseases, and government support for the development of new technologies.
AI-powered drug discovery platforms can help pharmaceutical companies to identify new drug targets and design new drugs more efficiently. This is expected to lead to the development of new and effective drugs that can improve the lives of patients.
Here are some statistics that support the forecast:
The following are some of the key players in the AI in Drug Discovery Market in Europe:
The AI in Drug Discovery Market in Europe is expected to continue to grow in the coming years. The growth of this market will be driven by the increasing demand for new and innovative drugs, the rising prevalence of chronic diseases, and government support for the development of new technologies.
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Mr. Aashish Mehra
630 Dundee Road
Northbrook, IL 60062
USA : 1-888-600-6441